About 15 years ago, I wrote an article about treating Alzheimer’s disease that divided treatments into two categories: “symptomatic” and “neuroprotectant.” There were real options in the former category. But the “neuroprotectant” idea was more theoretical — more of a “coming attractions” approach — citing the studies that were underway to identify treatments that would actually save brain cells, protecting those neurons from further harm, and actually slowing or arresting the disease process. Sadly, despite … Read More
OHSU Brain Institute
We are a national leader in brain disease treatment and research.Read more
- Stroke survivors continue to heal through the power of music
- Your health questions answered: What can I do to lower my risk of stroke?
- Researcher seeks better ways to care for people post-concussion